Multi-criteria decision analysis for assessment and appraisal of orphan drugs
Background: Limited resources and expanding expectations push all countries and types of health systems to adopt new approaches in priority setting and resources allocation. Despite best efforts, it is difficult to reconcile all competing interests and trade-offs are inevitable. This is why multi-cr...
Main Authors: | Georgi Iskrov, Tsonka Miteva-Katrandzhieva, Rumen Stefanov |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-09-01
|
Series: | Frontiers in Public Health |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fpubh.2016.00214/full |
Similar Items
-
Health economic data in reimbursement of new medical technologies: importance of the socio-economic burden as a decision-making criterion
by: Georgi Iskrov, et al.
Published: (2016-08-01) -
Criteria for Drug Reimbursement Decision-Making: An Emerging Public Health Challenge in Bulgaria
by: Georgi Iskrov, et al.
Published: (2016-02-01) -
Revealed preferences towards the appraisal of orphan drugs in Poland - multi criteria decision analysis
by: Katarzyna Kolasa, et al.
Published: (2018-04-01) -
What is the awareness of rare diseases among medical students? A survey in Bulgaria
by: Eleonora Hristova-Atanasova, et al.
Published: (2023-07-01) -
Expenditure trends of orphan drugs in Serbia: 8-Year analysis of orphan drug market in Serbia
by: Pejčić Ana V., et al.
Published: (2016-01-01)